Clinical trials recruiting for Pulmonary Disease, Chronic Obstructive

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
  NCT07780669 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
  NCT06755008 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
  NCT06959095 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 15 locations
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 159 locations
• Investigation of Walking Training With Different Slope Types in COPD Patients
  NCT06283004 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
  NCT05704881 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
  NCT05730088 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)
  NCT03807310 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Effect of Gait Training Using Different Slope Types on Balance in COPD Patients
  NCT06644898 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• The London COPD Exacerbation Cohort
  NCT02755974 · Phase: Not specified · Ages: 40 Years to 100 Years · Sex: All (male and female) · 1 location
• The ROAM Research Study Therapy (LTOT) Version
  NCT06810323 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Trial to Determine Effective Aspirin Dose in COPD
  NCT05265299 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
  NCT07177339 · Phase: Phase 3 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 121 locations

Related conditions

Trials recruiting for Pulmonary Disease, Chronic Obstructive often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Pulmonary Disease, Chronic Obstructive trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.